SIGYN THERAPEUTICS, INC. Shareholders' Equity
SIGYN THERAPEUTICS, INC. (SIGY) had Shareholders' Equity of -$5.92 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-14
- 2025-09-30: Stockholders' Equity Attributable to Parent -$5.92M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$5.44M.
- 2025-03-31: Stockholders' Equity Attributable to Parent -$4.95M.
- 2024-12-31: Stockholders' Equity Attributable to Parent -$4.46M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | -$5.92M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$5.44M 10-Q · filed 2025-11-14 | |
| 2025-03-31 | -$4.95M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | -$4.46M 10-Q · filed 2025-11-14 | |
| 2024-09-30 | -$3.92M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$3.67M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$4.02M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$3.41M 10-Q · filed 2025-11-14 | |
| 2023-09-30 | -$3.58M 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$3.04M 10-Q · filed 2024-11-19 | |
| 2023-03-31 | -$2.35M 10-Q · filed 2024-11-19 | |
| 2022-12-31 | -$1.90M 10-K · filed 2025-04-15 | |
| 2022-09-30 | -$1.74M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$1.18M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$731.57K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | -$264.58K 10-K · filed 2024-02-20 | |
| 2021-09-30 | $358.23K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $977.14K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$80.25K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $99.18K 10-K · filed 2023-03-31 | |
| 2020-09-30 | -$454.98K 10-Q · filed 2021-11-12 | -$2.82M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$188.74K 10-Q · filed 2021-11-12 | -$2.67M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $50.11K 10-Q · filed 2021-11-12 | -$2.57M 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$910.00 10-K · filed 2022-03-21 | -$2.46M 10-K · filed 2020-03-30 |
| 2019-09-30 | -$3.92M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$3.78M 10-Q · filed 2020-11-09 | -$3.78M 10-Q · filed 2019-08-05 |
| 2019-03-31 | -$3.66M 10-Q · filed 2020-08-07 | |
| 2018-12-31 | -$3.72M 10-Q · filed 2020-11-09 | |
| 2018-09-30 | -$2.68M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.46M 10-Q · filed 2019-08-05 | -$2.46M 10-Q · filed 2018-08-13 |
| 2018-03-31 | -$2.40M 10-Q · filed 2019-04-19 | |
| 2017-12-31 | -$2.09M 10-K · filed 2020-03-30 | |
| 2016-12-31 | -$691.84K 10-K · filed 2019-04-01 | |
| 2016-09-30 | -$1.24M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$975.22K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$414.79K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$82.01K 10-Q · filed 2016-11-14 | |
| 2015-09-30 | $21.97K 10-Q · filed 2015-12-21 | |
| 2014-12-31 | $99.43K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $24.53K 10-K · filed 2016-03-30 |